Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance

Anticancer Res. 1997 Jul-Aug;17(4B):2939-42.


Tumor markers CEA, CA19-9, CA15-3, CA125, AFP, beta-HCG, SCC were measured quantitatively in the serum, tumor tissue and healthy colonic mucosa of patients with colorectal cancer. We wanted to investigated whether there is a difference in concentration between patients with and without recurrence of cancer. During the follow-up period 14 of 38 patients showed tumor recurrence. The patients with cancer relapse had higher preoperative serum levels of CEA and CA19-9 and in the histologically normal colonic mucosa they had higher concentrations of CEA, CA19-9, SCC and low CA15-3. The highest values of CEA, CA19-9, and SCC occurred in the mucosa of patients developing local cancer recurrence. Marker concentrations in tumor tissues themselves did not differ between patients with or without tumor relapse. Though confirmation in a larger number of cases is needed we conclude from these results that tumor marker concentrations in the healthy colonic mucosa of patients with colorectal cancer may become valuable indicators of the risk of tumor recurrence.

MeSH terms

  • Biomarkers, Tumor / analysis*
  • CA-19-9 Antigen / analysis
  • Carcinoembryonic Antigen / analysis
  • Colon / chemistry
  • Colorectal Neoplasms / chemistry*
  • Humans
  • Mucin-1 / analysis
  • Neoplasm Recurrence, Local
  • Prognosis


  • Biomarkers, Tumor
  • CA-19-9 Antigen
  • Carcinoembryonic Antigen
  • Mucin-1